Topics
Technologies
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene...
Following a long-standing CGS tradition, we present a selection of our favorite Biopolitical Times posts of the past year.
In...
Scientists at UNSW Sydney have developed a new form of CRISPR technology that could make gene therapy safer while also
...
In our first article in this series, we investigated the dark PR tactics that have accompanied Colossal Bioscience’s de-extinction disinformation ...
Policies
For more than ten years, gestational surrogacy in Uruguay existed in a state of legal latency: provided for by law...
The United States Food and Drug Administration (FDA) has a unique funding structure among federal scientific and health agencies. The
...Following a long-standing CGS tradition, we present a selection of our favorite Biopolitical Times posts of the past year.
In...
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility...
Society
Genetic variants believed to cause blindness in nearly everyone who carries them actually lead to vision loss less than 30%...
Google has removed some of its artificial intelligence health summaries after a Guardian investigation found people were being put at...
This is the 10th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...
Menlo Ventures has made a $16 million bet that the “baby KJ” custom CRISPR therapy success story is...
Perspectives
In her book The Argonauts, Maggie Nelson describes pregnancy as an experience marked by a peculiar duality. On the...
One of the most interventionist approaches to technology governance in the United States in a generation has cloaked itself in...
There is growing concern that falling fertility rates will lead to economic and demographic catastrophe. The social and political movement...
Following a long-standing CGS tradition, we present a selection of our favorite Biopolitical Times posts of the past year.
In...